SEC 13F Intelligence

Marshall Wace North America L.P. / AZNN

Marshall Wace North America L.P.’s Astrazeneca PLC Position

Does Marshall Wace North America L.P. own Astrazeneca PLC (AZNN)? Yes — 1.66M shares worth $100M (+0.43% of its 13F portfolio) as of Q3 2021, down from 1.74M shares the prior filed quarter.

Position Value
$100M
Q3 2021
Shares
1.66M
% of Portfolio
+0.43%
Quarters Held
10
currently held

Position History AZNN

Reported value by quarter
Q1 ’19: $9MQ1 ’19Q2 ’19: $124MQ3 ’19: $152MQ3 ’19Q4 ’19: $107MQ1 ’20: $5MQ1 ’20Q2 ’20: $15MQ4 ’20: $23MQ4 ’20Q1 ’21: $87MQ2 ’21: $87MQ2 ’21Q3 ’21: $100Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20211.66M$100M+0.43%
Q2 20211.74M$87M+0.36%
Q1 20211.74M$87M+0.39%
Q4 2020465.8K$23M+0.12%
Q2 2020288.1K$15M+0.10%
Q1 2020116.7K$5M+0.04%
Q4 20192.14M$107M+0.52%
Q3 20193.41M$152M+0.86%
Q2 20193.01M$124M+0.77%
Q1 2019229.3K$9M+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marshall Wace North America L.P.’s full portfolio or all institutional holders of AZNN.